uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Silodosin Recordati
Authorised
Human
Details
EMA number
EMEA/H/C/004964
ATC code
G04CA04
Authorisation
7 January 2019
Revision
3
EMA page
Therapeutic indication
Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men.
MeSH:
Prostatic Hyperplasia
Group:
Urologicals;Alpha-adrenoreceptor antagonists
Active substances
silodosin
Marketing Authorisation Holder
Recordati Ireland Ltd
MAH
Timeline
Filter by authority:
EMA
Silodosin Recordati authorised
7 Jan 2019
authorised
regulatory
Silodosin Recordati | uMedical